OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
October 08, 2009
GlaxoSmithKline (London), Novartis (Basel, Switzerland), sanofi Aventis (Paris), and Baxter International (Deerfield, IL) recently provided updates as to the development, manufacture, or shipment of pandemic (H1NI) vaccines.
October 02, 2009
New nanotechnology-based delivery systems offer promise in drug delivery, particularly for anticancer therapeutics.
Abbott Laboratories (IL, USA) has agreed to acquire the pharmaceutical business of the Solvay Group (Belgium) for 4.5 billion Euros in cash.
October 01, 2009
The biopharmaceutical company Seattle Genetics (Bothell, WA) introduced a sugar-engineered antibody (SEA) technology that is designed to increase the potency of monoclonal antibodies through enhanced effector function.
Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash, according to an Abbott press release.
September 17, 2009
The Senate Finance Committee through its chairman, Max Baucus (D-MT), introduced on Sept. 16, 2009, a bill, "America's Healthy Future Act of 2009," representing the latest Congressional proposal for healthcare reform.